The Orlance Team
The Orlance team, headquartered in Seattle, WA, comprises industry and research experts across immunology, platform, and medical device/delivery and leverages many academic and industry collaborations.
KRIS AALTO, BS
CEO
25 years of bioengineering, innovation development, regulatory and clinical affairs, product launch, VC and executive experience.
DEB FULLER, PHD
CTO
Co-inventor of MACH-1 technology, formerly at PowderJect, UW Professor, the lab focuses on NA vaccines for multiple pathogens.
KEN BAGLEY, PHD
Director R&D
15 years in NA vaccine field, developed genetic adjuvant platform at Profectus Biosciences, Inc.
HANNAH FRIZZELL, PHD
Program Director, Preclinical Development
Preclinical Development Bioengineer, Immunology, and nano delivery system experience.
LYUDA LEBEDINSKI, BS
Senior Administrative and Financial Manager
Experienced biomedical research finance, federal funding and management professional.
Chris Press
Senior Research
Technician
10+ years in research and development, tech transfer from lab to cGMP formulation and QC
Ariana Aalto
Business/Product Development Intern
Formulation, engineering, QC, and business development support